Alerta De Seguridad para MitraClip Mitral Valve Repair System

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Abbott Vascular.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
  • Fecha de publicación del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: abbott mitraclip mitral valve repair system medical device manufacturer, abbott vascular, has issued a field safety notice concerning mitraclip mitral valve repair system (product number msk02st). abbott vascular has received a total of 4 reports since 2008 where the actuator knob of the clip delivery system was incorrectly turned in the clockwise direction during clip deployment. in the event that the actuator knob is incorrectly turned, the device may incur damage that prevents the deployment of the clip. additional medical intervention or conversion to surgery may then be required. the current inventory of product is acceptable for safe use following the steps highlighted in the instructions for use (ifu). patients that have had clips successfully implanted are not affected by this action. the manufacturer advises all users to consult the approved ifu that were distributed with each device, which contains important information for the proper clip deployment steps. specifically, step 17.2.2 states: “turn the actuator knob of the dc approximately 8 turns counterclockwise. if it is difficult to turn the actuator knob, confirm that the arm positioner moves freely. retract the actuator knob after it is fully unthreaded.” subsequent to this step, the following warning appears: “failure to stop turning the actuator knob when resistance is felt or turning the actuator knob in the clockwise direction may result in inability to deploy the clip.” furthermore, the manufacturer will add a directional arrow on the actuator knob of newly manufactured devices to aid in proper clip deployment. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 28 february 2013.


  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Abbott MitraClip Mitral Valve Repair System
  • Manufacturer


  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source